Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer' s disease and healthy subjects

被引:66
作者
Rosenmann, Hanna [1 ]
Meiner, Zeev
Geylis, Valeria
Abramsky, Oded
Steinitz, Michael
机构
[1] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91905 Jerusalem, Israel
关键词
tau protein; phosphorylated-tau; antibodies; tauopathy; Alzheimer's disease; autoimmunity;
D O I
10.1016/j.neulet.2006.01.072
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
While the presence of naturally occurring antibodies (Abs) against amyloid-beta in AD patients and healthy subjects have been repeatedly reported, no data on the presence of naturally occurring Abs against tau protein, in its unphosphorylated as well as its pathologically phosphorylated state, has been reported so far. We describe here the detection of circulating Abs against unphosphorylated and pathologically phosphorylated tau protein in sera of 17 aged subjects: nine Alzheimer's disease (AD) patients and eight healthy individuals. An ongoing autoimmune process may take place, as is suggested by the presence of both IgM class anti-tau Abs, as well as IgG. A preliminary evidence for higher anti-phosphorylated-tau Abs of IgM class in AD patients relative to controls is indicated, but demands further confirmation in a larger sample. Detection of naturally occurring anti-tau antibodies may point to the possibility that some autoimmune process may take place against the tau neuronal protein, including its pathologically phosphorylated state which compose the neurofibrillary tangles. Whether these Abs are neuroprotective or neurotoxic - is unknown, as it is with anti-amyloid-beta Abs. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:90 / 93
页数:4
相关论文
共 16 条
[1]   Reduced levels of amyloid β-peptide antibody in Alzheimer disease [J].
Du, Y ;
Dodel, R ;
Hampel, H ;
Buerger, K ;
Lin, S ;
Eastwood, B ;
Bales, K ;
Gao, F ;
Moeller, HJ ;
Oertel, W ;
Farlow, M ;
Paul, S .
NEUROLOGY, 2001, 57 (05) :801-805
[2]   AUTOANTIBODIES TO NEUROFIBRILLARY TANGLES AND BRAIN-TISSUE IN ALZHEIMERS-DISEASE - ESTABLISHMENT OF EPSTEIN-BARR VIRUS-TRANSFORMED ANTIBODY-PRODUCING CELL-LINES [J].
GASKIN, F ;
KINGSLEY, BS ;
FU, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) :245-250
[3]   Human monoclonal antibodies against amyloid-beta from healthy adults [J].
Geylis, V ;
Kourilov, V ;
Meiner, Z ;
Nennesmo, I ;
Bogdanovic, N ;
Steinitz, M .
NEUROBIOLOGY OF AGING, 2005, 26 (05) :597-606
[4]   Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease [J].
Gómez-Tortosa, E ;
Gonzalo, I ;
Fanjul, S ;
Sainz, MJ ;
Cantarero, S ;
Cemillán, C ;
Yébenes, JG ;
del Ser, T .
ARCHIVES OF NEUROLOGY, 2003, 60 (09) :1218-1222
[5]   Tau in Alzheimer's disease [J].
Mandelkow, EM ;
Mandelkow, E .
TRENDS IN CELL BIOLOGY, 1998, 8 (11) :425-427
[6]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[7]   MONOCLONAL-ANTIBODIES WITH SELECTIVE SPECIFICITY FOR ALZHEIMER TAU ARE DIRECTED AGAINST PHOSPHATASE-SENSITIVE EPITOPES [J].
MERCKEN, M ;
VANDERMEEREN, M ;
LUBKE, U ;
SIX, J ;
BOONS, J ;
VANDEVOORDE, A ;
MARTIN, JJ ;
GHEUENS, J .
ACTA NEUROPATHOLOGICA, 1992, 84 (03) :265-272
[8]   Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease [J].
Monsonego, A ;
Zota, V ;
Karni, A ;
Krieger, JI ;
Bar-Or, A ;
Bitan, G ;
Budson, AE ;
Sperling, R ;
Selkoe, DJ ;
Weiner, HL .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (03) :415-422
[9]   Autoantibodies to amyloid β-peptide (Aβ) are increased in Alzheimer's disease patients and Aβ antibodies can enhance Aβ neurotoxicity -: Implications for disease pathogenesis and vaccine development [J].
Nath, A ;
Hall, E ;
Tuzova, M ;
Dobbs, M ;
Jones, M ;
Anderson, C ;
Woodward, J ;
Guo, ZH ;
Fu, WM ;
Kryscio, R ;
Wekstein, D ;
Smith, C ;
Markesbery, WR ;
Mattson, MP .
NEUROMOLECULAR MEDICINE, 2003, 3 (01) :29-39
[10]   Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization [J].
Orgogozo, JM ;
Gilman, S ;
Dartigues, JF ;
Laurent, B ;
Puel, M ;
Kirby, LC ;
Jouanny, P ;
Dubois, B ;
Eisner, L ;
Flitman, S ;
Michel, BF ;
Boada, M ;
Frank, A ;
Hock, C .
NEUROLOGY, 2003, 61 (01) :46-54